These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27063404)

  • 1. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
    Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
    Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
    Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
    Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
    Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
    Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma.
    Wu BL; Lv GQ; Zou HY; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    ScientificWorldJournal; 2014; 2014():431792. PubMed ID: 25254241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
    Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma.
    Mizuno K; Seki N; Mataki H; Matsushita R; Kamikawaji K; Kumamoto T; Takagi K; Goto Y; Nishikawa R; Kato M; Enokida H; Nakagawa M; Inoue H
    Int J Oncol; 2016 Feb; 48(2):450-60. PubMed ID: 26676674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-protein interaction network analyses for elucidating the roles of LOXL2-delta72 in esophageal squamous cell carcinoma.
    Wu BL; Zou HY; Lv GQ; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2014; 15(5):2345-51. PubMed ID: 24716982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing factor hnRNPA1 regulates alternative splicing of LOXL2 to enhance the production of LOXL2Δ13.
    Pan D; Long L; Li C; Zhou Y; Liu Q; Zhao Z; Zhao H; Lin W; Zheng Z; Peng L; Li E; Xu L
    J Biol Chem; 2024 Jul; 300(7):107414. PubMed ID: 38810697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
    Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
    Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
    Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
    Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.
    Fong SF; Dietzsch E; Fong KS; Hollosi P; Asuncion L; He Q; Parker MI; Csiszar K
    Genes Chromosomes Cancer; 2007 Jul; 46(7):644-55. PubMed ID: 17394133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
    Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
    Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.